Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth M Taylor

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Parkinsonism & Related Disorders|December 15, 2020
A long-term follow-up of safety and clinical efficacy of NTCELL® [Immunoprotected (Alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's diseaseEoin Mulroy, Barry Snow, Arnold Bok, et al.
The Annals of Thoracic Surgery|July 26, 2006
Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patientsAxel Haverich, Stanton K Shernan, Jerrold H Levy, et al.
JAMA|May 20, 2004
Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trialEdward D Verrier, Stanton K Shernan, Kenneth M Taylor, et al.
Journal of Lipid Research|October 10, 2013
CDKN2B expression in adipose tissue of familial combined hyperlipidemia patientsStuart D Horswell, Lee G D Fryer, Claire E Hutchison, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Parkinsonism & Related Disorders|December 15, 2020
A long-term follow-up of safety and clinical efficacy of NTCELL® [Immunoprotected (Alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's diseaseEoin Mulroy, Barry Snow, Arnold Bok, et al.
The Annals of Thoracic Surgery|July 26, 2006
Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patientsAxel Haverich, Stanton K Shernan, Jerrold H Levy, et al.
JAMA|May 20, 2004
Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trialEdward D Verrier, Stanton K Shernan, Kenneth M Taylor, et al.
Journal of Lipid Research|October 10, 2013
CDKN2B expression in adipose tissue of familial combined hyperlipidemia patientsStuart D Horswell, Lee G D Fryer, Claire E Hutchison, et al.
Pageof 5